InsidersTradesSigma
Follow the Xbrane Biopharma AB stock price and the full insider trade history of the company, a listed equity based in Finland. Shares are quoted on FI FI, under the oversight of FIN-FSA. Operating in the Health Care sector, Xbrane Biopharma AB has published 0 insider filings. Market capitalisation: €209.1m. The full history is openly available.
Analysts rate Xbrane Biopharma AB Strong Buy (bullish), based on 1 analysts. Average price target: SEK 15.00.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
0 of 0 declarations
Xbrane Biopharma AB is a biopharmaceutical company focused on the development of biosimilars. It is listed on the XSTO market.